A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice
Summary: The importance of humoral immunity in combating TB has gained extensive recognition. In this study, a subunit vaccine named Ag85A-LpqH (AL) was prepared by fusing the antigen Ag85A proved to induce robust T cell immune responses, and LpqH was shown to produce protective antibodies. The prev...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | iScience |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589004224027950 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1841555714707816448 |
---|---|
author | Lingyuan Zeng You Zuo Minghui Tang Chengrui Lei Huoming Li Xiuling Ma Jiahong Ji Hao Li |
author_facet | Lingyuan Zeng You Zuo Minghui Tang Chengrui Lei Huoming Li Xiuling Ma Jiahong Ji Hao Li |
author_sort | Lingyuan Zeng |
collection | DOAJ |
description | Summary: The importance of humoral immunity in combating TB has gained extensive recognition. In this study, a subunit vaccine named Ag85A-LpqH (AL) was prepared by fusing the antigen Ag85A proved to induce robust T cell immune responses, and LpqH was shown to produce protective antibodies. The prevention and BCG prime-boost mouse models were established to test the vaccine efficacy. The results indicate that Ag85A-LpqH can induce substantial protection by reducing bacterial loads and pathological lesions. This vaccine can induce robust antibody responses, as well as T cell immune responses especially strong CD8+ T cell responses. Moreover, the serum from AL-immunized mice can reduce the bacterial load and lung pathology in mice. B cell receptor (BCR) sequencing revealed a notable rise in BCR diversity among mice immunized with AL. These results indicate that Ag85A-LpqH can be a promising vaccine candidate for tuberculosis prevention and control. |
format | Article |
id | doaj-art-e6d843185181424f95f5fbf160e24d5a |
institution | Kabale University |
issn | 2589-0042 |
language | English |
publishDate | 2025-01-01 |
publisher | Elsevier |
record_format | Article |
series | iScience |
spelling | doaj-art-e6d843185181424f95f5fbf160e24d5a2025-01-08T04:53:17ZengElsevieriScience2589-00422025-01-01281111568A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in miceLingyuan Zeng0You Zuo1Minghui Tang2Chengrui Lei3Huoming Li4Xiuling Ma5Jiahong Ji6Hao Li7National Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaNational Key Laboratory of Veterinary Public Health and Safety, College of Veterinary Medicine, China Agricultural University, Beijing, China; Corresponding authorSummary: The importance of humoral immunity in combating TB has gained extensive recognition. In this study, a subunit vaccine named Ag85A-LpqH (AL) was prepared by fusing the antigen Ag85A proved to induce robust T cell immune responses, and LpqH was shown to produce protective antibodies. The prevention and BCG prime-boost mouse models were established to test the vaccine efficacy. The results indicate that Ag85A-LpqH can induce substantial protection by reducing bacterial loads and pathological lesions. This vaccine can induce robust antibody responses, as well as T cell immune responses especially strong CD8+ T cell responses. Moreover, the serum from AL-immunized mice can reduce the bacterial load and lung pathology in mice. B cell receptor (BCR) sequencing revealed a notable rise in BCR diversity among mice immunized with AL. These results indicate that Ag85A-LpqH can be a promising vaccine candidate for tuberculosis prevention and control.http://www.sciencedirect.com/science/article/pii/S2589004224027950natural sciencesbiological sciencesimmunologymicrobiology |
spellingShingle | Lingyuan Zeng You Zuo Minghui Tang Chengrui Lei Huoming Li Xiuling Ma Jiahong Ji Hao Li A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice iScience natural sciences biological sciences immunology microbiology |
title | A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice |
title_full | A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice |
title_fullStr | A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice |
title_full_unstemmed | A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice |
title_short | A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice |
title_sort | subunit vaccine ag85a lpqh focusing on humoral immunity provides substantial protection against tuberculosis in mice |
topic | natural sciences biological sciences immunology microbiology |
url | http://www.sciencedirect.com/science/article/pii/S2589004224027950 |
work_keys_str_mv | AT lingyuanzeng asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT youzuo asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT minghuitang asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT chengruilei asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT huomingli asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT xiulingma asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT jiahongji asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT haoli asubunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT lingyuanzeng subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT youzuo subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT minghuitang subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT chengruilei subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT huomingli subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT xiulingma subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT jiahongji subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice AT haoli subunitvaccineag85alpqhfocusingonhumoralimmunityprovidessubstantialprotectionagainsttuberculosisinmice |